Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

It does appear to be building a base here. I would think the company has been holding because of or held back by the quorum issue. Once behind us I suspect there will be a steady streams of news over the next few months. I expect the news to include updates on Lympro sales/agreements, Lympro & MSPrecise CLIA timelines, ESS updates out of the Rutgers/Army Institute collaboration and the MANF Symposium (ODD for RAO approval?). Certainly any of those could spur some much needed institutional interest.